As patents expire, generic injectable semaglutide could become available at a fraction of current branded prices — around $28-$140 per person-year — in about 162 countries by the end of 2026.
Semaglutide (Ozempic®, Wegovy®, Rybelsus®) comes in both injection and oral form. But beyond how you take it, what's the difference? And which form is more effective for weight loss? Semaglutide ...
The first generic weight-loss GLP-1 injection Sevmia was recently approved by Health Canada. Here’s what you need to know.
JOHANNESBURG, July 20 (Reuters) - South Africa's Aspen Pharmacare said on Monday that its Canadian subsidiary had received ...
Glucagon-like peptide-1 receptor agonist (GLP-1) drugs, such as semaglutide, have become well known for their ability to aid in weight loss.
A generic semaglutide injection to promote weight loss is now approved in Canada, Health Canada says. The regulator said the product submission, called Svemia, was filed by Canadian-based Apotex and ...
This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. It’s hard to watch the news or scroll through social media without encountering stories about weight loss drugs like semaglutide (the ...
Shortages of injectable semaglutide (Novo Nordisk), sold under trade names Ozempic (for type 2 diabetes with or without established CVD) and Wegovy (for overweight or obesity), are forcing clinicians ...
According to Ian Neeland, MD, there are 2 main reasons for the shortage of injectable semaglutide: the fact that oral semaglutide has not yet been tested for weight loss, and that most practitioners ...
A Phase 3 trial found Eli Lilly's oral drug orforglipron outperformed oral semaglutide for weight loss and blood sugar control, though it caused more gastrointestinal side effects.
Sun Pharma has received South African approval for its generic semaglutide injection, expanding access to affordable ...
As demand for injectable weight-loss medicines grows, experts are urging South Africans to check whether their medication is SAHPRA-registered, warning that unregistered products may carry serious ...